OakChart

Concord Medical Services ADR

CCMHealthcare·Medical Care Facilities·China·Nano·NYSE·Nov 11 • 10:05 AM ET

3.61-0.07 (-1.90%)
2026-11-11 16:05 CET
Market cap
10.36 USD m
Revenue, TTM
64.13 USD m
Net income, TTM
-12.96 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-2.98
P/E
-
Compare

Price

CCM against its 20, 50 and 200-day averages
2050200
3.004.005.006.00259K517KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CCMclose 3.6120-day 3.7150-day 3.72200-day 4.223.61

46.9% under 6.80 on 4 May 2026. Last 15 sessions, 23.1% high to low

Profile

CCM
52-week range, 20% of the way up
2.796.80

Concord Medical Services Holdings Ltd. engages in the provision of operation of radiotherapy and diagnostic imaging centers. It operates through Network Business and Hospital Business segments. It provides radiotherapy and diagnostic equipment leasing services to hospitals, and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Employees610
IPODec 11, 2009
Beta-0.78
ATR, 14d0.37
Rel volume0.03
Short float0.09%
Insider own15.51%
Inst own0.79%

Snapshot

6 groups

Valuation

Index-
Market Cap10.18M
Enterprise Value1.05B
Income-12.96M
Sales64.13M
Book/sh-69.32
Cash/sh15.16
Dividend Est.-
Dividend TTM-
Dividend Ex-DateDec 23, 2015
Dividend Gr. 3/5Y- -
Payout-
Employees610
IPODec 11, 2009

Ratios

P/E-
Forward P/E-
PEG-
P/S0.16
P/B-
P/C0.24
P/FCF-
EV/EBITDA-
EV/Sales16.42
Quick Ratio0.46
Current Ratio0.48
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-2.98
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y43.80% 33.20%
Sales past 3/5Y-2.96% 14.67%
EPS Y/Y TTM69.68%
Sales Y/Y TTM20.26%
EPS Q/Q51.34%
Sales Q/Q58.57%
Earnings-
EPS/Sales Surpr.-237.42% 8.21%

Ownership

Insider Own15.51%
Insider Trans0.00%
Inst Own0.79%
Inst Trans-3.26%
ROA-1.39%
ROE-
ROIC-17.80%
Gross Margin5.67%
Oper. Margin-51.81%
Profit Margin-20.21%
SMA20-2.65%
SMA50-2.90%
SMA200-14.39%
Trades-

Technical

Shs Outstand2.82M
Shs Float2.38M
Short Float0.09%
Short Ratio0.05
Short Interest0.00M
52W High6.80 -46.91%
52W Low2.79 29.62%
Volatility6.35% 10.95%
ATR (14)0.37
RSI (14)48.06
Beta-0.78
Rel Volume0.03
Avg Volume40.82K
Volume157

Performance

Perf Week-2.43%
Perf Month-2.17%
Perf Quarter-21.69%
Perf Half Y-32.52%
Perf YTD-6.48%
Perf Year-27.22%
Perf 3Y-67.48%
Perf 5Y-85.56%
Perf 10Y-91.83%
Recom5.00
Target Price1.20
Prev Close3.68
Price3.61
Change %-1.90%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Dec 01, 2010InitiatedBBrean MurrayBuy$9+149.3%

Peers

Mkt cap
TickerCompanyMkt cap
AMSAmerican Shared Hospital Services8.12M
STLNStarling Oncology Inc445.70M
AUNAAuna SA340.09M
BMGLBasel Medical Group Ltd9.32M
ARAYAccuray Inc9.63M
ITOCiTonic Holdings Ltd13.38M
RDNTRadnet Inc6.23B
LMRILumexa Imaging Holdings Inc1.53B
ZCMDZhongchao Inc4.26M
AHGAkso Health Group ADR1.14B

News

latest 14 of 206
  • Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025 (PR Newswire)
  • Canagold Submits Environmental Application for the New Polaris Project (TMX Newsfile)
  • Concord Medical Schedules 2025 Annual Meeting of Shareholders (PR Newswire)
  • Concord Medical Reports Financial Results for the First Half of 2025 (PR Newswire)
  • Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma (PR Newswire) +5.39%
  • Loading…
  • Concord Medical Services Holdings Limited (CCM)'s Subsidiary Debuts Nation's First Proton Therapy LLM (Insider Monkey)
  • Concord Healthcare Announces Official Release of the Proton Therapy Large Model (PR Newswire)
  • Concord Medical Files Annual Report on Form 20-F for Fiscal 2024 (PR Newswire) +16.60% +13.03%
  • Concord Medical Announces Result of 2024 Annual General Meeting (PR Newswire) +5.56%
  • Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate (PR Newswire)
  • Concord Medical Schedules 2024 Annual Meeting of Shareholders (PR Newswire) +7.55%
  • Concord Medical Reports Financial Results for the First Half of 2024 (PR Newswire)
  • Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment (PR Newswire) +11.83%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2010FY4.1293.9843.90058.7257.97
2011FY-1.250-7.200-7.20072.7971.52
2012FY4.9604.7004.526107.87102.67
2013FY3.6183.3503.238160.98153.94
2014FY4.4494.3004.44997.82183.05
2015FY-1.3712.300-94.94113.96
2017FY-3.475-2.704-9.72252.7665.23
2018FY-2.9610.611-12.51828.4035.83
2019FY-0.332--18.41927.88-

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual-9.722-12.518-18.419-22.218-29.127-16.646-9.617-9.805-2.956
Period201720182019202020212022202320242025
EPS, quarterly
Period
Sales, annual48.97428.8528.70732.3175.29970.10875.8553.35164.063
Period201720182019202020212022202320242025
Sales, quarterly
Period
Shares, annual4.3362.8132.8152.8152.8152.8152.8152.8152.815
Period201720182019202020212022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue64.1364.0653.3575.8570.1175.3032.3128.7128.85
Cost of Goods Sold Incl. D&A60.5060.4764.3586.6692.7484.1230.4131.0025.86
Gross Profit3.633.59-11.00-10.81-22.63-8.821.90-2.292.99
Selling, General and Administrative Excl. Other36.8636.8962.9454.5355.3462.2446.4549.9847.39
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-33.23-33.29-73.94-65.35-77.97-71.06-44.55-52.27-44.40
Interest Expense21.1621.1926.8523.3817.8711.4411.794.156.99
Unusual Expense3.113.08-1.04-0.73-0.150.011.2311.010.82
Net Income Before Taxes-53.75-53.75-94.80-81.35-127.35-84.88-64.86-55.86-30.91
Income Taxes0.800.84-2.43-3.47-10.53-1.02-5.45-5.645.15
Consolidated Net Income-52.74-52.78-90.61-74.95-114.20-81.04-58.54-50.96-39.19
Net Income From Continuing Operations-12.96-12.91-42.83-42.01-72.72-42.09-44.91-44.44-35.50
Net Income-12.96-12.91-42.83-42.01-72.72-127.24-97.06-79.96-54.29
EPS (Recurring)-2.48-2.46-9.97-9.73-16.67-29.13-22.02-16.64-12.39
EPS (Basic, Before Extraordinaries)-2.98-2.96-9.80-9.62-16.65-29.13-22.22-18.42-12.52
EPS (Diluted)-2.98-2.96-9.80-9.62-16.65-29.13-22.22-18.42-12.52
EBITDA-12.47-12.53-55.78-47.22-58.25-54.93-32.92-42.75-37.60
Non-Operating Income (Expense)3.753.814.956.64-31.65-2.37-7.2911.5821.31
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense---0.00-0.661.712.242.241.04
Price To Sales Ratio0.260.260.440.631.021.163.704.035.35
Gross Margin5.675.61-20.62-14.26-32.28-11.725.87-7.9810.35
Operating Margin-51.81-51.97-138.60-86.15-111.22-94.38-137.89-182.09-153.91
Net Margin-20.21-20.15-80.28-55.39-103.72-168.98-300.39-278.54-188.18
Shares Outstanding2.822.822.822.822.822.822.822.822.81
Market Capitalization10.3610.3615.1530.9746.1756.3177.1475.10100.15

Income statement, quarterly

Currency USD, millions
Metric2025S22025S12024S22024S12023S22023S12022S22022S1
Total Revenue36.4827.6523.0130.3234.9441.0546.9622.26
Cost of Goods Sold Incl. D&A32.2628.2428.2436.0940.3546.4556.0835.95
Gross Profit4.23-0.59-5.23-5.76-5.41-5.40-9.12-13.69
Selling, General and Administrative Excl. Other17.5219.3541.3521.6428.9825.4830.9124.21
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-13.29-19.94-46.59-27.40-34.40-30.88-40.03-37.90
Interest Expense9.0812.0817.359.5211.2312.177.4510.54
Unusual Expense3.110.00-15.2714.16-0.720.00-0.150.00
Net Income Before Taxes-27.14-26.61-47.20-47.60-45.94-35.18-83.12-42.80
Income Taxes-1.932.73-1.23-1.20-0.16-3.38-8.77-1.49
Consolidated Net Income-24.43-28.31-45.05-45.55-44.30-30.35-72.60-40.46
Net Income From Continuing Operations-9.22-3.74-18.94-23.87-28.55-13.13-53.72-17.69
Net Income-9.22-3.74-18.94-23.87-28.55-13.13-53.72-17.69
EPS (Recurring)-1.62-0.86-6.82-3.20-6.69-3.00-12.40-4.05
EPS (Basic, Before Extraordinaries)-2.12-0.86-4.36-5.46-6.58-3.00-12.37-4.05
EPS (Diluted)-2.12-0.86-4.36-5.46-6.58-3.00-12.37-4.05
EBITDA-2.87-9.60-34.45-21.35-24.32-22.87-28.70-29.61
Non-Operating Income (Expense)-1.665.411.473.48-1.037.87-35.785.65
Stock Option Compensation Expense---0.00-0.00-0.91
Price To Sales Ratio0.260.490.440.640.630.681.031.21
Gross Margin11.58-2.13-22.75-19.01-15.49-13.15-19.42-61.51
Operating Margin-36.43-72.10-202.50-90.37-98.45-75.23-85.24-170.26
Net Margin-25.27-13.53-82.34-78.72-81.72-31.98-114.39-79.47
Shares Outstanding2.822.822.822.822.822.822.822.82
Market Capitalization10.3616.1315.1526.7530.9738.8546.1752.93

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments42.7550.9112.7522.9224.9151.8210.67127.70101.69
Short Term Receivables6.307.0110.3618.7420.4931.6927.7047.8255.63
Inventories6.584.585.6912.205.9812.681.482.054.53
Other Current Assets79.1672.3058.2355.4340.337.170.711.388.76
Total Current Assets134.79134.8087.03109.3091.71103.3740.55178.95170.61
Net Property, Plant & Equipment604.03578.85581.94554.40590.67489.18365.50270.50162.74
Total Investments and Advances60.3964.6955.6562.9961.3164.309.3256.96119.02
Long-Term Note Receivable---0.000.752.103.896.268.30
Intangible Assets118.50118.42126.72133.66194.52112.61106.6690.601.20
Deferred Tax Assets4.394.976.426.737.418.278.550.101.47
Other Assets19.2224.762.273.4638.5444.1491.0364.6070.28
Total Assets941.32926.49860.03870.54984.91823.97625.50667.97533.62
Short Term Debt Incl. Current Port. of LT Debt146.39147.71153.5078.9050.1824.8549.0064.17122.00
Accounts Payable17.0727.3218.2221.1116.082.851.190.790.70
Income Tax Payable1.080.220.210.120.000.130.110.550.92
Other Current Liabilities115.13115.93103.2161.1659.9650.4739.7861.2446.55
Total Current Liabilities279.67291.17275.15161.29126.2378.3190.08126.76170.17
Long Term Debt373.78390.81311.19384.28375.44335.11216.8672.4768.81
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities15.1316.3220.4622.9236.3531.7132.3024.2312.77
Other Liabilities7.996.556.9112.1016.3911.7315.0450.0865.17
Total Liabilities676.57704.85613.70580.58554.41456.86354.28273.53316.92
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-300.95-312.41-299.19-268.13-214.98-101.37-17.6263.71143.44
Total Shareholders Equity-300.95-312.41-299.19-268.13-214.98-101.37-17.6263.71143.44
Accumulated Minority Interest565.70534.05545.52558.08645.47468.48288.84330.7373.27
Total Equity264.75221.63246.33289.95430.50367.11271.22394.44216.71
Total Liabilities & Stockholders Equity941.32926.49860.03870.54984.91823.97625.50667.97533.62
Book Value Per Share-69.32-71.96-68.91-61.76-49.51-23.35-4.0614.6833.08
Tangible Book Value Per Share-148.98-153.02-151.28-142.71-145.44-76.00-44.15-9.5632.80
Full-Time Employees610595727918972851738584583
Price to Book Ratio-0.05-0.08-0.18-0.31-0.40-1.17-6.572.420.91
Return on Assets-1.38-4.79-4.86-7.84-4.65-6.20-6.87-5.91-8.43
Return on Equity-------192.84-34.27-27.03
Return on Invested Capital-17.73-54.64-350.23-62.61-26.23-19.21-22.30-26.07-19.82
Quick Ratio0.460.450.300.600.681.160.431.400.98
Current Ratio0.480.460.320.680.731.320.451.411.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income--52.78-90.61-74.95-114.20-81.04-58.54-50.96-39.19
Depreciation-20.7618.1718.1319.7216.1411.638.168.26
Deferred Taxes & Investment Tax Credit--1.09-2.17-1.84-10.671.75-1.93-3.251.13
Other Funds (Non Cash)-19.0940.0927.4057.3714.6720.2728.543.41
Funds from Operations--14.02-34.52-31.26-47.78-48.49-28.56-17.51-26.39
Extraordinary Item-0.000.000.000.000.000.000.000.00
Changes in Working Capital--13.61-20.75-7.7615.60-7.23-4.73-10.7622.31
Income Taxes Payable-0.830.010.100.12-0.130.02-0.44-6.91
Cash from Operating Activities--27.63-55.27-39.02-32.18-55.71-33.29-28.27-4.08
Capital Expenditures--12.71-57.09-16.92-57.15-120.99-74.31-101.52-115.79
Net Assets From Acquisitions--0.000.000.000.00-0.47-4.92-60.86-79.91
Sale of Fixed Assets and Businesses-9.531.2642.390.8495.28146.7212.2118.56
Purchase or Sale of Investments-18.73-26.6310.152.19-4.92-34.678.2222.34
Purchase of Investments-0.00-42.60-0.01-0.34-10.48-39.460.00-40.39
Sale Or Maturity of Investments-18.7315.9710.172.535.564.788.2262.73
Other Uses-0.000.000.000.000.000.00-15.210.00
Other Sources-0.00-0.0036.484.893.602.111.86
Cash from Investing Activities-15.55-82.4635.61-17.64-26.2136.41-155.07-152.94
Cash Dividends Paid-0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)-0.000.000.000.00----
Change in Capital Stock-0.000.000.000.000.000.000.000.00
Repurchase of Common Pref Stock-0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock-0.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options-0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net--51.1988.30-5.9856.8938.0751.1675.73-62.41
Change in Long Term Debt--47.1273.0814.4633.5331.1089.1498.49-41.63
Issuance of Long Term Debt-13.19266.3915.5362.7863.05124.18135.2371.42
Reduction of Long Term Debt--60.31-193.31-1.07-29.26-31.95-35.04-36.73-113.05
Net Financing Active Other Cash Flow-70.1470.940.000.000.000.00-1.45244.22
Other Financing Activities Uses-0.000.000.000.000.000.00-1.45-8.81
Cash from Financing Activities-18.95159.24-5.9856.8938.0751.1674.28181.81
Exchange Rate Effect-1.72-1.15-0.34-7.01-0.72-0.370.170.07
Net Change in Cash-8.5920.36-9.730.06-44.5853.91-108.8924.87
Free Cash Flow--40.33-110.94-55.35-89.17-173.64-106.41-129.71-119.59

Balance sheet, quarterly

Currency USD, millions
Metric2025S22025S12024S22024S12023S22023S1
Cash & Short Term Investments42.7527.5850.9146.3812.7536.42
Short Term Receivables6.308.017.0110.7710.3613.51
Inventories6.581.914.585.485.695.88
Other Current Assets79.16105.6072.3079.0458.2361.32
Total Current Assets134.79143.09134.80141.6787.03117.13
Net Property, Plant & Equipment604.03585.02578.85563.49581.94530.71
Total Investments and Advances60.3963.7864.6966.1855.6558.24
Intangible Assets118.50118.09118.42120.12126.72126.04
Deferred Tax Assets4.39-4.97-6.42-
Other Assets19.2229.7224.7619.992.273.51
Total Assets941.32939.71926.49911.46860.03835.63
Short Term Debt Incl. Current Port. of LT Debt146.39198.39147.71164.18153.50107.70
Accounts Payable17.0715.6627.3217.5218.2218.11
Income Tax Payable1.082.290.220.220.210.23
Other Current Liabilities115.13126.18115.93117.05103.2157.86
Total Current Liabilities279.67342.52291.17298.96275.15183.91
Long Term Debt373.78335.08390.81326.36311.19340.39
Deferred Tax Liabilities15.1311.1816.3212.7720.4614.54
Other Liabilities7.9910.616.559.006.919.36
Total Liabilities676.57699.39704.85647.09613.70548.20
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-300.95-312.53-312.41-294.35-299.19-258.38
Total Shareholders Equity-300.95-312.53-312.41-294.35-299.19-258.38
Accumulated Minority Interest565.70552.85534.05558.71545.52545.81
Total Equity264.75240.32221.63264.36246.33287.43
Total Liabilities & Stockholders Equity941.32939.71926.49911.46860.03835.63
Book Value Per Share-69.32-71.98-71.96-67.80-68.91-59.51
Tangible Book Value Per Share-148.98-152.95-153.02-147.21-151.28-136.54
Price to Book Ratio-0.05-0.08-0.08-0.14-0.18-0.23
Return on Assets-1.39-2.45-4.79-6.00-4.82-7.52
Return on Invested Capital-12.66-16.59-24.17-74.58-238.03-16.01
Quick Ratio0.460.410.450.460.300.60
Current Ratio0.480.420.460.470.320.64

Cash flow, quarterly

Currency USD, millions
Metric2025S22025S12024S22024S12023S22023S1

Revenue breakdown

Equipment Leasing Revenues2024: 1.30M 2025: 860.61K
Medicine income2024: 11.43M 2025: 11.09M
Services and other revenues2024: 40.69M 2025: 52.13M
Hospital2024: 37.60M 2025: 52.02M
Network2024: 15.82M 2025: 12.05M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.09%0.0M2.4M46.26K
2026-10-150.29%0.0M2.4M53.64K
2026-09-300.46%0.0M2.4M64.49K
2026-09-150.57%0.0M2.4M71.78K
2026-08-310.76%0.0M2.4M73.36K
2026-08-140.32%0.0M2.4M62.20K
2026-07-310.20%0.0M2.4M58.33K
2026-07-150.13%0.0M2.4M49.22K
2026-06-300.31%0.0M2.4M38.19K
2026-06-150.39%0.0M2.4M31.81K
2026-05-290.34%0.0M2.4M24.48K
2026-05-150.31%0.0M2.4M19.52K
2026-04-300.13%0.0M2.4M2.55K
2026-04-150.12%0.0M2.4M3.68K
2026-03-310.13%0.0M2.4M6.06K
2026-03-130.15%0.0M2.4M6.51K
2026-02-270.16%0.0M2.4M7.48K
2026-02-130.07%0.0M2.4M7.15K
2026-01-300.05%0.0M2.4M7.71K
2026-01-150.10%0.0M2.4M17.85K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-22SEC
2026-07-093Initial statement of beneficial ownership of securities2026-06-30SEC
2026-07-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-02SEC
2026-05-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-18SEC
2026-05-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-13SEC
2026-05-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-13SEC
2026-04-2920-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-12-31SEC
2026-04-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-15SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2025-12-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-02SEC
2025-09-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-09-30SEC
2025-09-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-09-26SEC
2025-08-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-08-28SEC
2025-07-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-07-29SEC
2025-07-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-07-22SEC
2025-07-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-07-14SEC
2025-07-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-07-07SEC
2025-06-256-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-25SEC
2025-06-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-20SEC
2025-06-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-04SEC
2025-05-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-29SEC
2025-05-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-29SEC
2025-05-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-13SEC
2025-05-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-08SEC
2025-04-2520-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2024-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
SmartHarvest Portfolios, LLC0.49%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.39%
CITADEL ADVISORS LLC0.37%
UBS Group AG0.02%
MORGAN STANLEY0.00%
JONES FINANCIAL COMPANIES LLLP0.00%
Caitong International Asset Management Co., Ltd0.00%
SBI Securities Co., Ltd.0.00%

Funds

Fund% owned
-

OakChart. CCM. Cached 15 minutes.

Some panels did not load: insider.